⚕ GalenOps CRO console
← SITE006 (GBR)

SITE006-0433

completed
Study: A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer Phase III · Site: SITE006 (GBR) (Dr. Rossi) · consented 2023-08-25
Adverse events
7
Serious AEs
1
Open data queries
0
Luna dropout signal
–

Adverse events

severe assessed 2026-08-18

Grade 3 Pneumonitis — outcome: RECOVERED/RESOLVED; onset 2023-09-26 (study day 26); relationship: not assessed

severe serious assessed 2026-08-18

Grade 4 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2023-10-22 (study day 52); relationship: not assessed; serious criteria: life-threatening

moderate assessed 2026-08-18

Grade 2 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-10-24 (study day 54); relationship: not assessed

severe assessed 2026-08-18

Grade 3 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-10-30 (study day 60); relationship: N

moderate assessed 2026-08-18

Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-12-16 (study day 107); relationship: not assessed

moderate assessed 2026-08-18

Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2024-03-30 (study day 212); relationship: not assessed

moderate assessed 2026-08-18

Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2024-05-05 (study day 248); relationship: not assessed

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.